Clioquinol inhibits zinc-triggered caspase activation in the hippocampal CA1 region of a global ischemic gerbil model

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Wang, Tao ^a   Zheng, Wei ^a   Xu, He ^a   Zhou, Jia Min ^a   Wang, Zhan You ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; CASPASE 3; CASPASE 9; CLIOQUINOL; ZINC; CHELATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMETALLOGRAPHY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; GERBIL; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; ENZYMOLOGY; METABOLISM;

GERBILLINAE;

ANIMALS; APOPTOSIS INDUCING FACTOR; BLOTTING, WESTERN; CA1 REGION, HIPPOCAMPAL; CASPASE 3; CASPASE 9; CASPASES; CHELATING AGENTS; CLIOQUINOL; ENZYME ACTIVATION; GERBILLINAE; IN SITU HYBRIDIZATION; MALE;

EID: 77955599608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011888     Document Type: Article

References (42)

1. Carboni S, Antonsson B, Gaillard P, Gotteland JP, Gillon JY, et al. (2005) Control of death receptor and mitochondrial-dependent apoptosis by c-Jun Nterminal kinase in hippocampal CA1 neurones following global transient ischaemia. J Neurochem 92: 1054-1060.
2. Hetz C, Vitte PA, Bombrun A, Rostovtseva TK, Montessuit S, et al. (2005) Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia. J Biol Chem 280: 42960-42970.
3. Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56: 149-171.
4. Smith ML, Auer RN, Siesjo BK (1984) The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol 64: 319-332.
5. Araki T, Kato H, Kogure K (1989) Selective neuronal vulnerability following transient cerebral ischemia in the gerbil: distribution and time course. Acta Neurol Scand 80: 548-553.
6. Kirino T (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239: 57-69.
7. Suh SW, Chen JW, Motamedi M, Bell B, Listiak K, et al. (2000) Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 852: 268-273.
8. Vallee BL, Coleman JE, Auld DS (1991) Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains. Proc Natl Acad Sci U S A 88: 999-1003.
9. O'Halloran TV (1993) Transition metals in control of gene expression. Science 261: 715-725.
10. Danscher G, Howell G, Perez-Clausell J, Hertel N (1985) The dithizone, Timm's sulphide silver and the selenium methods demonstrate a chelatable pool of zinc in CNS. A proton activation (PIXE) analysis of carbon tetrachloride extracts from rat brains and spinal cords intravitally treated with dithizone. Histochemistry 83: 419-422.
11. Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, et al. (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272: 1013-1016.
12. Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci 6: 449-462.
13. Diener HC, Schneider D, Lampl Y, Bornstein NM, Kozak A, et al. (2008) DPb99, membrane-activated metal ion chelator, as neuroprotective therapy in schemic stroke. Stroke 39: 1774-1778.
14. Barkalifa R, Hershfinkel M, Friedman JE, Kozak A, Sekler I (2009) The ipophilic zinc chelator DP-b99 prevents zinc induced neuronal death. Eur J Pharmacol 618: 15-21.
15. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits betaamyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676.
16. Yu H, Zhou Y, Lind SE, Ding WQ (2009) Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 417: 133-139.
17. Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, et al. (2007) Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res 67: 1636-1644.
18. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59: 43-55.
19. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, et al. (2006) Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281: 17670-17680.
20. Ibach B, Haen E, Marienhagen J, Hajak G (2005) Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report. Pharmacopsychiatry 38: 178-179.
21. Regland B, Lehmann W, Abedini I, Blennow K, Jonsson M, et al. (2001) Treatment of Alzheimer's disease with clioquinol. Dement Geriatr Cogn Disord 12: 408-414.
22. Ritchie CW, Bush AI, Masters CL (2004) Metal-protein attenuating compounds and Alzheimer's disease. Expert Opin Investig Drugs 13: 1585-1592.
23. Hegde ML, Bharathi P, Suram A, Venugopal C, Jagannathan R, et al. (2009) Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis 17: 457-468.
24. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37: 899-909.
25. Nguyen T, Hamby A, Massa SM (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci U S A 102: 11840-11845.
26. Calderone A, Jover T, Mashiko T, Noh KM, Tanaka H, et al. (2004) Late calcium EDTA rescues hippocampal CA1 neurons from global ischemiainduced death. J Neurosci 24: 9903-9913.
27. Danscher G, Stoltenberg M (2006) Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem 41: 57-139.
28. Strosznajder R, Gajkowska B (2006) Effect of 3-aminobenzamide on Bcl-2, Bax and AIF localization in hippocampal neurons altered by ischemia-reperfusion injury. the immunocytochemical study. Acta Neurobiol Exp (Wars) 66: 15-22.
29. Park JA, Lee JY, Sato TA, Koh JY (2000) Co-induction of p75NTR and p75NTR-associated death executor in neurons after zinc exposure in cortical culture or transient ischemia in the rat. J Neurosci 20: 9096-9103.
30. Danscher G (1982) Exogenous selenium in the brain. A histochemical technique for light and electron microscopical localization of catalytic selenium bonds. Histochemistry 76: 281-293.
31. Frederickson CJ, Kasarskis EJ, Ringo D, Frederickson RE (1987) A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J Neurosci Methods 20: 91-103.
32. Nitzan YB, Sekler I, Frederickson CJ, Coulter DA, Balaji RV, et al. (2003) Clioquinol effects on tissue chelatable zinc in mice. J Mol Med 81: 637-644.
33. Medvedeva YV, Lin B, Shuttleworth CW, Weiss JH (2009) Intracellular Zn2+ accumulation contributes to synaptic failure, mitochondrial depolarization, and cell death in an acute slice oxygen-glucose deprivation model of ischemia. J Neurosci 29: 1105-1114.
34. Jiang D, Sullivan PG, Sensi SL, Steward O, Weiss JH (2001) Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J Biol Chem 276: 47524-47529.
35. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446.
36. Colbourne F, Corbett D (1994) Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res 654: 265-272.
37. Gupta S, Sharma SS (2006) Neuroprotective effects of trolox in global cerebral ischemia in gerbils. Biol Pharm Bull 29: 957-961.
38. Suh SW, Frederickson CJ, Danscher G (2006) Neurotoxic zinc translocation into hippocampal neurons is inhibited by hypothermia and is aggravated by hyperthermia after traumatic brain injury in rats. J Cereb Blood Flow Metab 26: 161-169.
39. Gao HL, Zheng W, Xin N, Chi ZH, Wang ZY, et al. (2009) Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspasedependent and -independent signaling pathways. Neurotox Res 16: 416-425.
40. Zhang LH, Wang X, Zheng ZH, Ren H, Stoltenberg M, et al. (2010) Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol Aging 31: 74-87.
41. Doering P, Stoltenberg M, Penkowa M, Rungby J, Larsen A, et al. (2010) Chemical blocking of zinc ions in CNS increases neuronal damage following traumatic brain injury (TBI) in mice. PLoS One 5: e10131.
42. Xu H, Gao HL, Zheng W, Xin N, Chi ZH, et al. (2010) Lactational zinc deficiency-induced hippocampal neuronal apoptosis by a BDNF-independent TrkB signaling pathway. Hippocampus. DOI: 10.1002/hipo.20767.